Literature DB >> 18784102

NHERF1 mutations and responsiveness of renal parathyroid hormone.

Zoubida Karim1, Bénédicte Gérard, Naziha Bakouh, Rohia Alili, Christine Leroy, Laurent Beck, Caroline Silve, Gabrielle Planelles, Pablo Urena-Torres, Bernard Grandchamp, Gérard Friedlander, Dominique Prié.   

Abstract

Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium-hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans. 2008 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784102     DOI: 10.1056/NEJMoa0802836

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  75 in total

Review 1.  The expanding family of hypophosphatemic syndromes.

Authors:  Thomas O Carpenter
Journal:  J Bone Miner Metab       Date:  2011-12-14       Impact factor: 2.626

2.  Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis.

Authors:  Yun-Sok Ha; Dong-Un Tchey; Ho Won Kang; Yong-June Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim
Journal:  Korean J Urol       Date:  2010-01-21

3.  Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains.

Authors:  Juan A Ardura; Bin Wang; Simon C Watkins; Jean-Pierre Vilardaga; Peter A Friedman
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

Review 4.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

5.  Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.

Authors:  W Bruce Sneddon; Giovanni W Ruiz; Luciana I Gallo; Kunhong Xiao; Qiangmin Zhang; Youssef Rbaibi; Ora A Weisz; Gerard L Apodaca; Peter A Friedman
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

Review 6.  [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism].

Authors:  J Bacchetta; P Cochat; I B Salusky
Journal:  Arch Pediatr       Date:  2011-04-16       Impact factor: 1.180

7.  Loss of NHERF-1 expression prevents dopamine-mediated Na-K-ATPase regulation in renal proximal tubule cells from rat models of hypertension: aged F344 rats and spontaneously hypertensive rats.

Authors:  Michelle T Barati; Corey J Ketchem; Michael L Merchant; Walter B Kusiak; Pedro A Jose; Edward J Weinman; Amanda J LeBlanc; Eleanor D Lederer; Syed J Khundmiri
Journal:  Am J Physiol Cell Physiol       Date:  2017-05-17       Impact factor: 4.249

Review 8.  Pediatric stone disease.

Authors:  Stacy T Tanaka; John C Pope
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

Review 9.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

10.  Ligand-induced dynamic changes in extended PDZ domains from NHERF1.

Authors:  Shibani Bhattacharya; Jeong Ho Ju; Natalia Orlova; Jahan Ali Khajeh; David Cowburn; Zimei Bu
Journal:  J Mol Biol       Date:  2013-04-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.